NDAINHALATIONGAS
Approved
Jun 2013
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
7
Data completeness
3/8 — Basic
NITROGEN, NF (nitrogen) by Advanced Solutions Life Sciences. Approved for critical illness, postoperative complications, nutrition therapy and 6 more indications. First approved in 2013.
Drug data last refreshed 20h ago · AI intelligence enriched 1w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
NITROGEN, NF is an inhaled pharmaceutical-grade nitrogen gas approved for medical use across a diverse range of indications including critical illness, postoperative complications, nutrition therapy, and various neoplastic and respiratory conditions. The product is a simple gas formulation with no defined mechanism of action, functioning as a basic medical gas rather than a traditional pharmacologic agent. Patient applications span acute care settings, surgical recovery, and specialized treatment of conditions ranging from gastrointestinal neoplasms to bronchopulmonary dysplasia.
Peak
Product is in peak lifecycle with no reported Part D spending data; limited commercial visibility suggests niche positioning requiring specialized sales and medical affairs support.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Worked on NITROGEN, NF at Advanced Solutions Life Sciences? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.